Abstract
The legal, psychosocial, and medical factors that we believe have contributed to the success of our protocol-contract in prescribing opioids to patients with chronic pain not due to malignancy are outlined. These factors may be applicable to the treatment of a variety of chronic nonmalignant pain syndromes such as postherpetic neuralgia or human immunodeficiency virus/acquired immunodeficiency syndrome. The intended target audience of this paper is the physician (primary care, chronic pain specialist) who is involved in prescribing opioids for the treatment of chronic, nonmalignant pain.
MeSH terms
-
Acquired Immunodeficiency Syndrome / physiopathology
-
Analgesics, Opioid / administration & dosage
-
Analgesics, Opioid / therapeutic use*
-
Chronic Disease
-
Clinical Protocols*
-
Drug Prescriptions
-
Drug Tolerance
-
Drug and Narcotic Control / legislation & jurisprudence
-
Florida
-
HIV Infections / physiopathology
-
Herpesviridae Infections / physiopathology
-
Humans
-
Legislation, Medical
-
Neuralgia / drug therapy
-
Neuralgia / virology
-
Opioid-Related Disorders
-
Pain / drug therapy*
-
Pain / physiopathology
-
Pain / psychology
-
Pain, Intractable / drug therapy
-
Pain, Intractable / physiopathology
-
Pain, Intractable / psychology
-
Treatment Outcome
-
United States